These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 364647)

  • 21. Prophylaxis of postoperative deep venous thrombosis. Studies on low-dose heparin, blood coagulation, infection as a risk factor and the half-life of fibrinogen in patients after gastrointestinal surgery.
    Törngren S
    Acta Chir Scand Suppl; 1979; (495):1-69. PubMed ID: 397454
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombotic and thromboembolic complications and their prevention with heparin].
    Kucherskiĭ VM
    Urol Nefrol (Mosk); 1983; (2):69-74. PubMed ID: 6190288
    [No Abstract]   [Full Text] [Related]  

  • 23. Ancrod: a practical alternative to heparin.
    Cole CW; Bormanis J
    J Vasc Surg; 1988 Jul; 8(1):59-63. PubMed ID: 3385879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Heparin and prevention of deep-vein thrombosis.
    Sharnoff JG
    Lancet; 1973 Nov; 2(7838):1148. PubMed ID: 4128036
    [No Abstract]   [Full Text] [Related]  

  • 25. Possible pathway for formation of fibrin degradation products during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Nature; 1975 Jun; 255(5510):638-40. PubMed ID: 1134556
    [No Abstract]   [Full Text] [Related]  

  • 26. Aspirin prophylaxis of venous thromboembolic disease following fracture of the upper femur.
    Channon GM; Wiley AM
    Can J Surg; 1979 Sep; 22(5):468-72. PubMed ID: 497917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo production of soluble complexes containing fibrinogen-fibrin related antigen during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Thromb Res; 1975 Sep; 7(3):361-72. PubMed ID: 1188838
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of ancrod in acute or progressing ischemic cerebral infarction.
    Olinger CP; Brott TG; Barsan WG; Hedges JR; Glas-Greenwalt P; Pollak VE; Spilker J; Eberle R
    Ann Emerg Med; 1988 Nov; 17(11):1208-9. PubMed ID: 3056131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled trial of the sequential use of streptokinase and ancrod in the treatment of deep vein thrombosis of lower limb.
    Tibbutt DA; Chesterman CN; Williams EW; Faulkner T; Sharp AA
    Thromb Haemost; 1977 Apr; 37(2):222-32. PubMed ID: 577626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Low molecular heparin in prevention of thrombosis in orthopedic surgery].
    Jensen HP; Borris LC; Lassen MR; Sørensen JV; Rahr HB; Christiansen HM; Ejstrud P
    Ugeskr Laeger; 1993 Apr; 155(15):1109-15. PubMed ID: 8387708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation system changes induced by pelvic surgery and the effect of Dextran 70.
    Bonnar J; Walsh JJ; Haddon M; Fairweather J; Denson KW
    Bibl Anat; 1973; 12():351-5. PubMed ID: 4597634
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of severe foot ischaemia by defibrination with ancrod: a randomized blind study.
    Tønnesen KH; Sager P; Gormsen J
    Scand J Clin Lab Invest; 1978 Sep; 38(5):431-5. PubMed ID: 360366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis against thrombosis in femoral neck fractures--a comparison between dextran 70 and dicumarol.
    Bronge A; Dahlgren S; Lindquist B
    Acta Chir Scand; 1971; 137(1):29-35. PubMed ID: 4112897
    [No Abstract]   [Full Text] [Related]  

  • 35. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
    Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
    [No Abstract]   [Full Text] [Related]  

  • 36. Heparin versus dextran in the prevention of deep-vein thrombosis. A multi-unit coctrolled trial.
    Lancet; 1974 Jul; 2(7873):118-20. PubMed ID: 4135556
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of the recurrences of chronic thromboembolic disease.
    Kounis NG; Evans WH
    Br J Clin Pract; 1979 Oct; 33(10):283-5. PubMed ID: 526413
    [No Abstract]   [Full Text] [Related]  

  • 38. Lower extremity thrombophlebitis in patients with femoral neck fractures. A venographic investigation and a review of the early and late significance of the findings.
    Stevens J; Fardin R; Freeark RJ
    J Trauma; 1968 Jul; 8(4):527-34. PubMed ID: 5658635
    [No Abstract]   [Full Text] [Related]  

  • 39. Medical treatment of deep vein thrombosis.
    Sharp A
    Proc R Soc Med; 1975 Apr; 68(4):265. PubMed ID: 1197330
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.
    Lancet; 2000 Apr; 355(9212):1295-302. PubMed ID: 10776741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.